MAGI-2 Inhibits cell migration and proliferation via PTEN in human hepatocarcinoma cells

被引:63
作者
Hu, Yali
Li, Zengxia
Guo, Liang
Wang, Uying
Zhang, Lineng
Cai, Xiumei
Zhao, Hongbo
Zha, Xiliang [1 ]
机构
[1] Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Shanghai 200032, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Minist Hlth, Key Lab Glycoconjugate Res, Shanghai 200433, Peoples R China
关键词
MAGI-2; PTEN; human hepatocarcinoma cell lines; cell migration; cell proliferation; TUMOR-SUPPRESSOR PTEN; TIGHT JUNCTION PROTEIN; GUANYLATE KINASE; PDZ-DOMAIN; PTEN/MMAC1; MUTATIONS; POSTSYNAPTIC DENSITY; PHOSPHATASE-ACTIVITY; INTERACTING PROTEIN; PROSTATE-CANCER; S-SCAM;
D O I
10.1016/j.abb.2007.07.027
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MAGI-2, a multidomain scaffolding protein, contains nine potential protein-protein interaction modules, including a GuK domain, two WW domains and six PDZ domains. In this study, we examined eight human hepatocarcinoma, cell lines (HHCCs) and found that MAGI-2 was expressed only in 7721 cells. After 7721, 7404 and 97H cells were transfected with myc-MAGI-2 plasmid, their migration and proliferation was significantly inhibited, which was associated with downregulation of p-FAK and p-Akt. It is known that p-FAK is a substrate of PTEN and p-Akt can be regulated by PTEN via PIP3. We demonstrated that PTEN was upregulated after myc-MAGI-2 transfection, which was due to the enhancement of PTEN protein stability rather than mRNA levels. Furthermore, MAGI-2-induced inhibition of cell migration and proliferation was attenuated in 7721 cells with PTEN silence or in PTEN-null cell line U87MG, and PTEN transfection could restore the effect of MAGI-2 in U87MG cells. Finally, the molecular association between PTEN and MAGI-2 was confirmed. Our results suggested that PTEN played a critical role in MAGI-2-induced inhibition of cell migration and proliferation in HHCCs. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 54 条
  • [31] PDZ domains bind carboxy-terminal sequences of target proteins
    Saras, J
    Heldin, CH
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 1996, 21 (12) : 455 - 458
  • [32] Molecular organization of the postsynaptic specialization
    Sheng, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (13) : 7058 - 7061
  • [33] Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.3.CO
  • [34] 2-9
  • [35] Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
    Stambolic, V
    Suzuki, A
    de la Pompa, JL
    Brothers, GM
    Mirtsos, C
    Sasaki, T
    Ruland, J
    Penninger, JM
    Siderovski, DP
    Mak, TW
    [J]. CELL, 1998, 95 (01) : 29 - 39
  • [36] Vinculin controls PTEN protein level by maintaining the interaction of the adherens junction protein 6-catenin with the scaffolding protein MAGI-2
    Subauste, MC
    Nalbant, P
    Adamson, ED
    Hahn, KM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (07) : 5676 - 5681
  • [37] SUDIPTO D, 2003, P NATL ACAD SCI USA, V100, P7491
  • [38] SAPAPs - A family of PSD-95/SAP90-associated proteins localized at postsynaptic density
    Takeuchi, M
    Hata, Y
    Hirao, K
    Toyoda, A
    Irie, M
    Takai, Y
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (18) : 11943 - 11951
  • [39] Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN
    Tamura, M
    Gu, JG
    Matsumoto, K
    Aota, S
    Parsons, R
    Yamada, KM
    [J]. SCIENCE, 1998, 280 (5369) : 1614 - 1617
  • [40] Tashiro H, 1997, CANCER RES, V57, P3935